Press release
Antisense Oligonucleotide Therapeutics Market Forecast Reflects Strong Revenue Growth Fueled by Regulatory Approvals and Strategic Collaborations
Antisense Oligonucleotide Therapeutics Market
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1245
Antisense oligonucleotides (ASOs) are short, single-stranded DNA or RNA sequences designed to selectively bind to messenger RNA (mRNA) within cells. By modulating mRNA translation, ASOs inhibit the production of disease-associated proteins while leaving already synthesized proteins unaffected. This precise mechanism of action positions ASOs as a promising therapeutic modality for a wide range of medical conditions, including diabetes, asthma, alopecia, inflammatory disorders, and central nervous system diseases.
In addition to their therapeutic applications, ASOs are widely employed in genomic research to study gene expression and regulatory pathways. Clinically approved antisense therapies, such as mipomersen for elevated cholesterol and fomivirsen for cytomegalovirus (CMV) retinitis, highlight the potential of this technology. The capacity of ASOs to regulate gene expression at the mRNA level has established them as a critical tool in the development of precision medicine, particularly for genetic disorders.
The global antisense oligonucleotide therapeutics market is experiencing significant growth, driven by increased adoption of ASO-based treatments, rising research and development investments, a growing prevalence of neurological disorders, and an aging population. Regulatory approvals from agencies such as the U.S. Food and Drug Administration (FDA) for emerging ASO therapies are expected to further support market expansion. Additionally, strategic collaborations and acquisitions aimed at strengthening therapeutic pipelines are likely to accelerate sector development.
However, the high cost of ASO therapies and the availability of alternative synthetic treatment options may pose challenges to market growth. Regulatory complexities also present ongoing considerations for industry stakeholders. Despite these constraints, continued investment by leading market participants is expected to create new opportunities and drive sustained revenue growth over the forecast period.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Regionally, Europe is projected to be a significant contributor to the antisense oligonucleotide therapeutics market, driven by the increasing adoption of innovative antisense drugs. Leading European companies are actively pursuing strategic mergers and acquisitions, alongside initiatives to expand and strengthen their antisense oligonucleotide product portfolios, thereby reinforcing the region's competitive market position.
Similarly, the North American antisense oligonucleotide therapeutics market is expected to experience substantial growth over the forecast period. Numerous biotechnology firms have made significant investments in the development of RNA interference (RNAi) therapies, while major pharmaceutical companies have engaged in strategic partnerships and licensing agreements with smaller enterprises to capitalize on the anticipated revenue potential within the market.
Major market players operating in the Antisense Oligonucleotide Therapeutics market include Pharmaceuticals, Inc., Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Inc., Antisense Therapeutics Limited, Sarna Therapeutics GmbH, Arrowhead Pharmaceuticals, Inc., Atlantic Pharmaceuticals, Inc., GlaxoSmithKline plc, Gerona Corporation, Gradualist, ICO Therapeutics, Aptos Biosciences, Enzo Pharmaceuticals, Inc., Bio-Path Holdings, Inc., Gene Signal International SA, Marina Biotech, mirage Therapeutics, Inc., Synodic, Inc., Oncogene Pharmaceuticals Inc., Pharm axis Ltd, Regulus Therapeutics Inc., Reran Pharmaceuticals, Inc., and RI Pharmaceuticals, among others.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1245
Recent collaborations and agreements in the market:
• In January 2021, MilliporeSigma (US) acquired AmpTec, a well-known German business specializing in contract development and manufacturing mRNA (CDMO).
• In August 2019, Integrated DNA Technology released tools- oligo pools, a set of 350-nucleotide-long, high-quality DNA oligonucleotides (US).
Market Segments
Global Antisense Oligonucleotide Therapeutics Market, by Therapy, 2022-2030 (Value US$ Mn)
• Monotherapy
• Combination
Global Antisense Oligonucleotide Therapeutics Market, by Molecule Target Indication, 2022-2030 (Value US$ Mn)
• DNA Molecule
• RNA Molecule
Global Antisense Oligonucleotide Therapeutics Market, by Target Indication, 2022-2030 (Value US$ Mn)
• Duchenne Muscular Atrophy
• Spinal Muscular Atrophy
• Familial Chylomicronemia Syndrome
• Amyotrophic Lateral Sclerosis
• Familial Partial Lipodystrophy
• Hereditary Transthyretin-Mediated (hatter) Amyloidosis
• Huntington's Disease
• Others
Global Antisense Oligonucleotide Therapeutics Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Antisense Oligonucleotide Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Antisense Oligonucleotide Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Antisense Oligonucleotide Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Antisense Oligonucleotide Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Antisense Oligonucleotide Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
o Rest of Middle East & Africa
Read Overview Report- https://www.insightaceanalytic.com/report/global-antisense-oligonucleotide-therapeutics-market/1245
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antisense Oligonucleotide Therapeutics Market Forecast Reflects Strong Revenue Growth Fueled by Regulatory Approvals and Strategic Collaborations here
News-ID: 4155367 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Radiotheranostics Market Insights Emphasize Rising Need for Accurate Diagnosis a …
"Radiotheranostics Market" in terms of revenue was estimated to be worth USD 2.54 billion in 2024 and is poised to reach USD 8.73 billion by the year 2034, growing at a CAGR of 6.0% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1499
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global radiotheranostics market are:
• Technological…
AI-Based Digital Pathology Solutions Market Outlook Highlights Increasing Demand …
Global AI-Based Digital Pathology Solutions Market is predicted to grow at an 8.6% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1492
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the AI-based digital pathology solutions market are:
• Technological advancement
• Increasing chronic diseases
• Expanding knowledge of cutting-edge medical treatment
The following are the primary obstacles to the AI-based digital pathology solutions market 's expansion:
• Expensive price…
Menstrual Health Apps Market Trends Reflect Emerging Health-Tech Startups and In …
Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Menstrual Health Apps Market (By Applications (Period Cycle Tracking, Fertility & Ovulation Management And Menstrual Health Management),Platform (Android, Ios And Others))- Market Outlook And Industry Analysis 2034"
The global menstrual health apps market is estimated to reach over 4384.7 Mn by the year 2034, exhibiting a CAGR of 16.7% during the forecast period.
Get Free Access…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
